The state of Montana currently has 1 active clinical trials seeking participants for Multiple Sclerosis research studies. These trials are conducted in various cities, including Billings, Missoula, Great Falls and Kalispell.
Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)
Recruiting
To compare the efficacy and safety of remibrutinib versus teriflunomide in patients with relapsing multiple sclerosis (RMS)
Gender:
ALL
Ages:
Between 18 years and 55 years
Trial Updated:
06/03/2025
Locations: SCL Health, Billings, Montana
Conditions: Relapsing Multiple Sclerosis